PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,672,641 | psychometr analysi valid daili sexual minor stressor scale among young adult sex femal coupl sexual minor women experi greater health dispar relat heterosexu women thought due uniqu stressor relat sexual ident daili diari momentari assess may provid nuanc approach understand sexual minor stressor relat health behavior cross section studi provid date valid measur examin daili sexual minor stressor recent pilot studi develop brief item measur assess sexual minor stressor self identifi lesbian most lesbian women heron et al although optim number item generat best captur daili experi lesbian women psychometr examin valid new measur necessari use multilevel confirmatori factor analysi among fulli scale sampl sexual minor women present studi establish daili sexual minor stressor scale good model fit unidimension measur ie one factor level analysi intraclass correl indic major variat within person addit establish converg discrimin valid use similar measur singl item assess general stressor negat affect histori discrimin heterosex final criterion valid support daili level experienc daili sexual minor stressor associ signific greater likelihood drink alcohol day experienc daili sexual minor stressor studi period signific associ histori harass discrimin victim isol vigil also accept concern difficult process intern homoneg psycinfo databas record c apa right reserv | D018452;D018454;D013315;D011795 | T057;T098;T099;T055;T170;T048;T081;T058;T062 |
34,672,640 | import employ worker preexist behavior health disord covid pandem littl known employ experi peopl preexist behavior health condit coronavirus diseas covid pandem despit recogn import work group | D001008;D000086382;D003863;D004651;D058873 | T047;T184;T098;T048;T067;T033;T080 |
34,672,639 | address sexual intim relat communiti mental health servic peopl serious mental ill qualit studi mental health practition experi literatur experi mental health provid mhps work peopl serious mental ill smi communiti base mental health program relat sex sexual intimaci scarc purpos present studi explor situat thought feel dilemma challeng experienc mhps around issu | D003156;D001523 | T058;T048 |
34,672,638 | development contextu model coupl synchroni across adulthood old age theoret model social dynam govern develop health across adulthood old age reli singl unit approach put forth development contextu model cosynch util concept synchroni interdepend fluctuat physiolog state health behavior novel way conceptu social development dynam use sampl case romant partner model aim innov integr avail find address everyday microsoci dynam dyad contribut overal partner concord health trajectori specif model build proposit integr exist empir find infus futur research proposit p synchroni shape close share context p synchroni physiolog health behavior follow u shape curv younger older adult coupl show greater synchroni middl age coupl greater diversif synchroni old age p coupl synchroni profound shape life event p synchroni correl pertin individu dyad characterist p effect everyday coupl synchroni accumul time therebi carri signific implic health involv parti also point open question suggest futur direct appli model go advanc knowledg social health dynam under adult develop age psycinfo databas record c apa right reserv | D000375 | T040;T033 |
34,672,637 | emot show problem transpar estim women borderlin person disord featur transpar estim estim extent one mental state observ other requir simultan represent self other perspect self individu borderlin person disord bpd difficulti integr multipl perspect mental may reflect impair transpar estim total particip high low bpd featur watch emot evoc video clip estim transpar emot experi facial express code softwar faceread quantifi object transpar individu high bpd featur show larger discrep estim object transpar individu low bpd featur show underestim transpar inde estim transpar posit predict object transpar individu low bpd featur individu high bpd featur moreov abil estim intraindividu variabl one object transpar moder self report arous particip high bpd featur impair transpar estim correl self report measur borderlin featur attach mental conclus found borderlin featur relat reduc capac estim extent one emot state observ other although replic clinic sampl bpd patient need present studi provid evid problem mental embodi self anoth person perspect bpd psycinfo databas record c apa right reserv | D001883;D000076563 | T048;T041 |
34,672,636 | relationship intervent indirect buffer financi strain effect biolog age among black adult black adult rural south experi elev financi strain contextu stressor increas risk poor health support relationship particular posit romant relationship shown offset risk present studi aim provid experiment evid buffer effect support relationship test whether particip relationship enhanc program prosaaf improv coupl function barton beach well et al subsequ buffer effect cumul financi strain biolog age weather postintervent financi strain assess four time deoxyribonucl acid dna extract peripher whole blood collect year baselin n individu pattern methyl use index acceler pace age coupl function treat latent construct compris four self report indic effect communic relationship confid relationship satisfact perceiv partner support result indic cumul financi strain associ acceler pace age medium larg effect size effect moder chang coupl function individu greater improv coupl function show less epigenet age respons cumul financi strain addit signific indirect buffer effect prosaaf associ cumul financi strain acceler pace age first studi demonstr coupl focus prevent intervent reduc impact financi strain rate age enhanc coupl function psycinfo databas record c apa right reserv | D001741;D000375 | T040;T033;T098 |
34,672,635 | increment valid primaci predictor everyday function verbal memori predictor later function deficit howev unclear specif aspect immedi free recal drive relationship serial posit effect ie relationship word placement word list likelihood recal shown predict convers mild cognit impair mci alzheim diseas ad goal studi determin serial posit effect predict function year postbaselin control demograph variabl total cognit score | D000544;D060825 | T048;T047 |
34,672,631 | barrier lower effect baird antiaromat photoinduc proton coupl electron transfer pcet reaction mani popular organ chromophor catalyz photoinduc proton coupl electron transfer pcet reaction aromat ground state becom excit state antiaromat lowest state show excit state antiaromat make electron transfer easier two repres photoinduc electron transfer process investig photolysi phenol solar water split pyridin water complex select reaction direct electron transfer opposit net result proton transfer follow direct electron transfer nucleus independ chemic shift nic ionize energi electron affin pcet energi profil select n n system present import mechanist implic discuss | D004583 | T196;T081 |
34,672,630 | synthesi preclin evalu f sifa psma inhibitor prostat cancer model positron emiss tomographi pet imag prostat specif membran antigen psma gallium ga fluorin f radiotrac arous tremend interest past year use organosilicon f fluorid acceptor sifa conjug urea base peptidomimet psma inhibitor provid kit like multidos synthesi technolog nine novel f label sifa bear psma inhibitor differ linker moieti synthes analyz vitro bind taag psma lncap cell ic valu rang nm among compound f sifa asp peg psma ic nm show highest tumor uptak lncap tumor suv min substanti increas molar activ gbqmol led signific increas lncap tumor uptak suv min correspond vivo block dcfpyl result uptak min sifa isotop exchang chemistri offer method readili adapt kit type label procedur clinic translat | D049268 | T060 |
34,672,629 | cyclosporin conform complex chameleon chameleon behavior cyclosporin csa investig conform ensembl employ multicanon molecular dynam simul could sampl cis tran isom n methyl amino acid assess conduct explicit water dimethyl sulfoxid acetonitril methanol chloroform cyclohexan chx n hexan hex use amber ff amber eht amber eht amber eht forc field conform detail discuss employ free energi landscap fel k observ experiment determin structur csa part conform space compar roesi measur chx hex major conform apolar solvent essenti cdcl except observ sidechain rotam effect metal ion conform includ cistran isomer also investig base analysi fel conclud amber ff forc field best describ experiment deriv conform indic csa intrins form membran permeabl conform metal ion might key cistran isomer n methyl amino acid bind partner protein | D016572;D056004 | T044;T116;T121;T066 |
34,672,628 | pharmaceut lauryl sulfat salt preval format rule formul implic anion surfact sodium lauryl sulfat sls known deterior dissolut drug form poor solubl lauryl sulfat ls salt howev percept infrequ occurr phenomenon usual investig drug develop unexpect dissolut slowdown encount work demonstr preval phenomenon compound divers chemic structur includ salt basic drug quaternari ammonium salt organ base zwitterion molecul precipit solut mix sls although precipit observ compound ftir spectra suggest intermolecular interact sls dri solut result along exampl report literatur demonstr preval phenomenon occurr precipit thermodynam driven relat differ ion product solut q solubl product lauryl sulfat salt k sp sls surfact also affect precipit kinet influenc interfaci tension nuclei insolubl salt potenti issu associ ls salt identifi effect mitig strategi proactiv design implement allevi possibl negat impact drug dissolut | D012492;D013501 | T120;T104;T122 |
34,672,625 | isopolymolybd incorpor metal organ framework sulfit oxidas mimick activ photocatalyt oxid sulfid util situ generat singlet oxygen develop new photocatalyst sulfid oxid util situ generat signific inspir natur enzymat process synthes mimic sulfit oxidas co mo tpt como tpt incorpor isopolymolybd anion mo tri pyridyl triazin tpt base metal organ framework mild hydrotherm condit structur mo unit intrins like catalyt site benefici select oxid sulfit thioether ultraviolet visibl spectra como tpt exhibit strong absorpt nm potenti applic util solar energi mott schottki measur indic como tpt n type semiconductor lumo valu v vs nhe homo valu v transient photocurr respons strong current densiti cycl visibl light indic como tpt high photochem activ lower resist indic como tpt higher effici photoinduc electron hole separ como tpt display high effici select photocatalyt oxid sulfid util situ generat tandem process format h follow catalyz disproportion h | D000073396 | T109 |
34,672,623 | lewi base catalyz sulfenium ion initi enantioselect spiroket cascad lewi base catalyz enantioselect sulfenocycl alken afford spiroket develop method use chiral lewi base catalyst electrophil sulfur sourc generat enantioenrich thiiranium ion alken upon format thiiranium ion subsequ captur cascad type reaction wherein keton oxygen serv nucleophil open thiiranium ion alcohol provid secondari cyclize form biorelev spiroket varieti electron rich electron neutral e substitut styren form desir spiroket good yield excel enantio diastereoselect alkyl substitut termin alken particip cascad reaction limit scope compar styrenyl substrat method allow rapid format high substitut spiroket good yield excel enantioselect | D000475;D058115 | T120;T109 |
34,672,619 | circular antisens oligonucleotid specif rnase h mediat microrna inhibit reduc target effect nonspecif immunostimul antisens microrna oligodeoxynucleotid amo power tool regul microrna function unfortun sever target effect sometim observ due special topolog enzymat properti circular oligodeoxynucleotid c odn ration design develop circular amo effect inhibit microrna function high target specif low target effect bind enzymat assay indic small circular amo could select bind digest target matur mir suggest topolog properti circular c odn signific decreas target effect microrna inhibitor compar linear correspond phosphorothio amo circular phosphorothio amo could effect reduc amount carcinogen mir mir upregul express level downstream antitumor protein pten pdcd addit c ps antimir induc much less nonspecif immunostimulatori effect compar linear partner ps odn indic advantag circular odn nonspecif immunostimul | D007114 | T061 |
34,672,618 | target colon cancer cell enzym trigger casein gate releas cargo mesopor silica base nanoparticl colorect cancer crc one wide diagnos cancer worldwid despit notabl improv therapeut strategi avail crc patient late stage crc higher incid rate drug resist associ higher mortal rate develop therapeut strategi use nanoparticl drug deliveri system becom one promis potenti approach cancer therapi previous studi shown natur plant alkaloid veratridin vtd suppress colon cancer cell migrat invas two essenti factor tumor metastasi activ gene encod tumor suppressor protein ubxna goal studi develop nanoassembl select deliv vtd cancer cell releas demand leav normal cell intact packag target therapi anticanc molecul vtd insid mesopor silica nanoparticl msns imperm blood brain barrier bbb select affin crc cell seal vtd load nanoparticl enzymat cleavabl protein particl deliv releas vtd target colorect tumor site sinc enzym mmp proteas domin secret crc cell releas trigger enzym increas vtd concentr tumor cell enhanc effici new therapi proven select affin two type vtd carri particl crc cell enzym acid trigger vtd releas negat surfac charg msns show signific affin toward posit charg cancer cell negat charg normal fibroblast colon cell make vtd msns promis anticanc drug minim side effect | D003110 | T191 |
34,672,617 | consider thermodynam kinet effect relat humid electrolyt electrochem toxic gas sensor paper physic chemistri absorpt desorpt water vapor electrochem gas sensor common use sulfur acid electrolyt investig electrochem gas sensor increas use monitor toxic gase environ principl simpl devic practic oper complex particular chang atmospher humid temperatur signific effect sensor output model develop calcul sensor weight chang humid vari good agreement analysi experiment result allow calcul rather import electrolyt volum variat chang acid molar physic characterist electrolyt also determin effect work electrod electrocatalyt activ discuss potenti problem sensor environment monitor highlight particular chang electroact area consequ sensor output flood catalyst aggreg lead problem electrolyt leakag sensor consid | D004573;D005740 | T121;T104;T197 |
34,672,616 | hierarch self assembl metal ion modul chitosan tubul soft materi gel biolog tissu develop via self assembl chemo mechan forc report instantan format soft tubular structur two level hierarchi inject mixtur inorgan salt chitosan cs solut reactor fill alkalin solut fold wrinkl instabl occur origin smooth surfac control salt composit concentr liesegang like precipit pattern develop outer surfac length scale presenc calcium chlorid precipit particl distribut even bulk corrobor x ray ct hand barium hydroxid precipit thin outer layer cs tubul barium chlorid introduc cs solut independ concentr weak interact salt electr potenti gradient across cs membran develop vanish ph differ two side membran diminish | D048271 | T121;T109 |
34,672,615 | long rang dipol dipol interact plasmon lattic spontan emiss quantum emitt enhanc increas local densiti optic state wherea engin dipol dipol interact requir modifi two point spectral densiti function experiment demonstr long rang dipol dipol interact ddis mediat surfac lattic reson plasmon nanoparticl lattic use angl resolv spectral measur fluoresc lifetim studi show uniqu nanophoton mode mediat long rang ddi donor acceptor molecul observ signific persist ddi strength rang densiti map nm mean nearest neighbor separ distanc donor acceptor dipol factor larger free space result pave way engin control long rang ddis ensembl emitt room temperatur | D053758 | T073 |
34,672,614 | kinet analysi mass transfer zinc myoglobin singl mesopor silica particl confoc fluoresc microspectroscopi adsorptiondesorpt mechan biomolecul porous materi attract signific attent applic mani field includ environment medic industri scienc employ confoc fluoresc microspectroscopi reveal diffus behavior zinc myoglobin znmb nm nm nm spheric protein singl mesopor silica particl pore size nm measur time cours fluoresc depth profil particl reveal intraparticl diffus rate limit process znmb particl diffus coeffici znmb particl distribut dis releas process determin rate constant eg dis cm cm mm buffer solut obtain valu various buffer concentr analyz use pore surfac diffus model although surfac diffus main distribut process releas process involv pore surfac diffus observ small organ molecul mechan transfer small molecul pore diffus alon demonstr mass transfer kinet znmb silica particl explain well basi pore surfac diffus | D009211;D015032 | T116;T121;T196;T123 |
34,672,613 | ph respons associ behavior biocompat random copolym contain pendent phosphorylcholin fatti acid well defin ph respons biocompat random copolym compos methacryloyloxi ethyl phosphorylcholin vari quantiti sodium acrylamido undecano aau f aau mol synthes via revers addit fragment chain transfer radic polymer ph respons associ dissoci behavior random copolym studi via turbid h nuclear magnet reson relax time dynam light scatter static light scatter sls fluoresc measur basic ph level random copolym dissolv water unim state aau unit behav hydrophil manner result ionize pendent fatti acid random copolym f aau mol associ intramolecular within singl polym chain form unim micell ph proton pendent fatti acid hand random copolym f aau mol form intermolecular aggreg compos four polym chain ph establish sls measur random copolym display abil solubil hydrophob guest molecul n phenyl naphthylamin hydrophob microdomain form pendent dehydr fatti acid acid phs ph pyrememethanol captur random copolym f aau mol releas random copolym ph furthermor mucoadhes properti random copolym f aau mol studi use surfac plasmon reson techniqu copolym adsorb onto mucin ph howev adsorpt decreas ph | D005227;D010767 | T121;T168;T109;T123 |
34,672,611 | situ observ nanofibril nucleat growth electrochem polymer poli ethylenedioxythiophen use liquid phase transmiss electron microscopi electrochem deposit poli ethylenedioxythiophen pedot carri previous presenc varieti counterion previous studi shown elong nanofibrillar structur pedot would form reproduc certain counterion poli acryl acid paa ad reaction mixtur howev detail nanofibril nucleat growth stage yet clear describ structur evolut pedot nanofibril use liquid phase transmiss electron microscopi lptem measur growth veloc nanofibril differ direct various stage process intens profil estim number edot monom involv observ fibril initi grew anisotrop direct nomin perpendicular local edg electrod rate faster along length compar along width thick real time observ help us elucid nucleat growth pedot nanofibril electrochem deposit | D019086;D011108 | T104;T122;T109 |
34,672,610 | direct detect low abund gene singl point mutat cell free dna cfdna analysi specif circul tumor dna ctdna analysi provid enorm opportun noninvas earli assess cancer date pcr base method led field howev limit sensitivityspecif pcr base method necessit search new method describ direct approach detect kras gd mutat gene clinic ctdna sampl utmost lod sensitivityspecif studi mut protein immobil tip atom forc microscop afm protein sens mismatch site duplex form captur probe surfac mutat dna noteworthi lod copi allel frequenc achiev along superb sensitivityspecif observ demonstr forc base afm combin protein found natur proper design captur probesblock repres excit new avenu ctdna analysi | D000074141;D009369 | T191;T114 |
34,672,606 | advanc util human plasma proteom studi protein circul blood offer tremend opportun diagnos stratifi possibl prevent diseas recent technolog advanc urgent need understand effect covid proteom analysi blood deriv serum plasma becom even import studi human biolog pathophysiolog provid view perspect technolog develop possibl clinic applic use mass spectrometri ms affin base method discuss exampl plasma proteom contribut valuabl insight sar cov infect age hemostasi opportun offer combin proteom genet data contribut human proteom organ hupo human plasma proteom project hppp present human plasma peptideatla build compris canon addit nonredund human protein detect ms base experi addit report new human extracellular vesicl peptideatla compris five studi canon protein detect extracellular vesicl circul blood common plasma peptideatla overview summar recent advanc impact applic ongo challeng translat plasma proteom util precis medicin | D020543 | T116;T123 |
34,672,600 | irek mediat cell wall protect phosphoryl enterococcus faecali enterococcus faecali gram posit bacterium major caus hospit acquir infect due part intrins resist cell wall activ antimicrobi one critic determin resist transmembran kinas irek belong penicillin bind protein serinethreonin kinas associ kinas famili bacteri signal protein involv regul cell wall homeostasi activ irek enhanc respons cell wall stress direct substrat irek phosphoryl lead antimicrobi resist larg unknown better understand stress modul phosphoryl event contribut antimicrobi resist wild type e faecali cell treat cell wall activ antimicrobi chlorhexidin ceftriaxon examin via phosphoproteom among promin chang increas phosphoryl divisom compon treatment suggest e faecali modul cell divis respons cell wall stress phosphoryl mediat irek determin via similar analysi e faecali irek mutant strain reveal potenti irek substrat involv regul peptidoglycan biosynthesi within e faecali crosr two compon system anoth signal transduct pathway promot antimicrobi resist result reveal critic insight biolog function irek | D002473;D013293 | T026;T007 |
34,672,599 | ph control stereoregular polymer poli methyl methacryl vesicl membran report ph control stereoregular polymer methyl methacryl mma insid membran h cooh hyperbranch polym vesicl use common radic polymer process vesicl size decreas nm increas solut ph isotact obtain polymethyl methacryl pmmas accord elev obtain isotact rich pmmas show lower glass transit temperatur depend isotact commerci random pmmas mechan studi accord situ fourier transform infrar measur indic control polym isotact result monom conform confin effect insid thin vesicl membran present studi provid new method realiz prepar isotact polym characterist facil synthesi ph control green polymer process aqueous solut well mild reaction condit ambient temperatur pressur | D011108;D019904 | T104;T122;T109 |
34,672,596 | concert motion molecular function physic chemistri learn light driven ion pump rhodopsin transmembran ion gradient generat maintain ion pump protein cell light driven ion pump rhodopsin retin contain protein found archaea bacteria eukarya photoisomer retin chromophor induc structur chang protein allow transport ion particular direct understand unidirect ion transport ion pump rhodopsin excit challeng biophys chemistri concert chang ion bind affin ion bind site protein key unidirect ion transport coupl chromophor protein moieti drive concert motion regul ion bind affin common ion pump rhodopsin protein structur divers ion pump function suggest univers principl govern ion transport would wide applic molecular system perspect review insight obtain previous studi rhodopsin discuss futur perspect | D012243;D025604 | T116;T123 |
34,672,594 | stereochemistri conform dynam stabil liquid crystal phase although discot liquid crystal dimer wide target organ semiconductor lc glass former role conform dynam self assembl flexibl mesogen remain poor understood effort probe effect investig impact linker stereochemistri phase behavior discot liquid crystallin dimer diastereomer dibenzo c phenazin diester prepar r r meso butanediol dimer form columnar phase meso isom clear temperatur c c higher chiral diastereom conform analysi via dft calcul h nmr dosi experi indic compound adopt predomin extend conform meso dimer show stronger prefer unfold solut probe conform alter phase stabil prepar deriv catechol hydroquinon act rigid linker lock dimer fold extend conform respect diester hydroquinon possess c near c higher catechol deriv consist model extend conform stabil lc phase extend dimer also exhibit higher transit enthalpi c indic columnar phase order fold structur | D050866 | T104;T073 |
34,672,591 | synthesi enantioenrich disubstitut chroman lewi base catalyz carbosulfenyl method catalyt enantioselect carbosulfenyl alken construct disubstitut chroman describ alken activ proceed intermediaci enantioenrich configur stabl thiiranium ion generat catalyt lewi base activ electrophil sulfenyl agent transform afford difficult generat enantioenrich disubstitut chroman moder high yield excel enantioselect varieti substitu compat includ electron divers function group well sever function handl aryl halid ester anilin phenol result thioether moieti amen number function group manipul transform notabl pendant sulfid success cleav furnish free thiol readili provid access sulfur contain function group present natur product pharmaceut | D002839;D058115 | T120;T109 |
34,672,590 | electron properti protein destabil stabil implic preferenti bind exclus mechan studi electron properti low weight organ co solut mean conceptu densiti function theori calcul result highlight import role certain chemic reactiv descriptor chemic hard electroneg nucleofug electrofug import criteria classifi protein stabil destabil result impli lewi basic properti lower chemic hard stabil destabil show higher lewi acid higher chemic hard consider analyt calcul term transfer energi reveal crucial role co solut protein interact signific chang interact pattern stabil destabil speci correspond outcom connect statist thermodynam electron properti co solut also allow us defin general principl strong stabil destabil | D004581 | T090 |
34,672,589 | direct cyclopropan quinolinium zwitterion thiolat via dearom reaction one pot two step protocol synthesi librari remark function sulfon analogu bab tetrahydro h cyclopropa c thiazino quinolin describ class various function molecular skeleton obtain cyclopropan quinolinium zwitterion thiolat reaction pathway involv format cycloaddit intermedi follow cycloaddit | D011804 | T109 |
34,672,586 | ultrafast structur vibrat dynam cyano contain non fulleren acceptor organ solar cell reveal two dimension infrar spectroscopi non fulleren molecul itic bis methylen dicyanomethylen indanon tetraki hexylphenyl dithieno indaceno b b dithiophen among promis non fulleren acceptor organ solar cell osc work use cyano stretch mode vibrat marker structur vibrat energi dynam itic examin ultrafast time scale two dimension infrar spectroscopi two ir activ mode studi main correspond two anti symmetr combin symmetr asymmetr stretch vibrat two cn mode origin two c cn chromophor locat across itic system found signific larger diagon anharmon correspond diagon anharmon indic strong anharmon vibrat coupl two mode support ab initio anharmon frequenc comput transient ir result indic picosecond intramolecular vibrat energi transfer two cn mode upon excit structur basi vibrat energet featur conjug molecular frame compos network singledoubl bond connect two c cn chromophor may enabl effici vibrat deloc addit well known electron deloc capabl import result osc applic discuss | D014732 | T070 |
34,672,584 | design synthesi structur activ relationship optim pyrazolopyrimidin amid inhibitor phosphoinositid kinas pik phosphoinositid kinas pik high express immun cell promot product migrat inflammatori mediat inhibit pik shown repolar tumor immun microenviron inflammatori phenotyp therebi control immun suppress cancer herein report structur base optim earli lead seri pyrazolopyrimidin isoindolinon culmin discoveri high potent isoform select pik inhibitor favor drug like properti x ray cocryst structur analysi molecular dock studi detail structur activ relationship investig result identif optim amid isoindolinon substitu achiev desir combin potenc select metabol stabil preliminari vitro studi indic inhibit pik compound result signific immun respons increas pro inflammatori cytokin gene express macrophag | D015195;D055808 | T062;T090 |
34,672,582 | machin learn approach calcul electron coupl quasi diabat molecular orbit case dna diabat one electron state flexibl molecular aggreg great challeng due presenc surfac cross molecular orbit mo level complex interact mos neighbor molecul work present effici machin learn approach calcul electron coupl quasi diabat mos without need nonadiabat coupl calcul use mos rigid molecul refer mos direct regard quasi diabat molecular dynam select state track phase correct basi inform artifici neural network train character structur depend onsit energi quasi diabat mos intermolecular electron coupl repres sequenc dna systemat studi illustr smooth time evolut electron coupl base pair obtain quasi diabat mos particular method calcul electron coupl differ quasi diabat mos independ thus possess uniqu advantag mani applic | D004583;D000069550;D011789 | T170;T066;T196;T081 |
34,672,579 | biomimet total synthes chloropupukeananin chloropupukeanolid chloropestolid chloropupukeananin chloropupukeanolid chloropestolid famili structur complex bioactiv natur product possess high function tricyclo decan bicyclo octan skeleton biosynthesi chloropupukeananin famili trigger intermolecular heterodimer diel alder reaction maldoxin iso ac howev enzym involv yet identifi herein report one pot biomimet synthesi chloropupukeananin chloropupukeanolid moreov effect solvent intermolecular diel alder reaction siccayn maldoxin suggest biosynthesi chloropupukeananin famili involv diel alderas catalyz heterodimer diel alder reaction | D032701;D012717 | T090;T109 |
34,672,578 | mechanist insight bioil induc structur alter dmpc lipid bilay emerg applic risk tradit ionic liquid il toward ecosystem chang percept regard green result explor biocompat altern known biocompat il bioil investig impact two biocompat cholinium amino acid base il structur behavior model homogen dmpc dimyristoyl sn glycero phosphocholin lipid bilay use atom molecular dynam simul techniqu two classic cholinium amino acid base il cholinium glycin ch gli cholinium phenylalanin ch phe differ side chain length hydrophob anion util present work simultan analysi bilay structur properti reveal exist ch gli bioil particular concentr induc phase transit fluid phase gel phase dmpc lipid bilay freez lipid bilay upon exposur concentr aqueous solut ch gli bioil indic harm bioil toward cell membran major contain dmpc lipid cell freez negat affect stabil function despit hydrophob amino acid side chain phe anion ch phe case bilay ch phe system observ minim impact ch phe bioil dmpc bilay properti mol concentr presenc bioil observ thicken bilay accumul cation anion bioil interfac dmpc lipid head tail transfer free energi profil phe anion aqueous phase membran center also indic anion partit lipid head tail interfac inabl penetr lipid membran tail region contrast free energi profil gli anion offer high energi barrier insert gli membran interior lead accumul gli anion lipid head water region | D052578;D008051 | T026;T120;T103 |
34,672,577 | acceler vibrat energi relax water alkalin environ observ hydrat hydroxid ion introduc addit relax channel vibrat relax od vibrat hdo molecul aqueous naoh solut addit relax path involv reson frster vibrat energi transfer excit od vibrat oh stretch vibrat hydrat oh complex energi transfer constitut effici mechan dissip od vibrat energi accept oh stretch vibrat show extrem rapid subsequ relax time constant fs find frster energi transfer character frster radius | D014732;D014867 | T070;T121;T197 |
34,672,576 | total synthesi chimer glycolipid bear partial acetyl backbon spong deriv agminosid e describ total synthesi chimer glycolipid bear partial acetyl backbon spong deriv agminosid e r hydroxydecano acid chain bacteri rhamnolipid branch pentaglucolipid skeleton achiev use disconnect approach glycosid bond synthes combin nisyb otf tmsotf mediat stereoselect glycosyl thiotolyl n phenyltrifluoroacetimid trichloroacetimid donor late stage pentaacetyl stauding reduct azidomethyl benzoyl group follow continu flow microfluid hydrogenolysi complet total synthesi structur simplifi glycolipid whose partial acetyl pattern glycan part ident agminosid e studi lay foundat total synthesi spong deriv agminosid understand biolog function spong | D006017;D011134 | T121;T109;T123 |
34,672,572 | ozon initi human deriv emiss nanoclust aerosol nanoclust aerosol ncas particl nm import player drive climat feedback process impact human health studi report first time nca format gas phase ozon react human surfac occupi climat control chamber detect nca ozon present nca emiss depend cloth coverag occup age air temperatur humid ozon initi chemistri human skin lipid particular primari surfac reaction product key mechan drive nca emiss evidenc posit correl squalen human skin wipe sampl known gaseous product ozonolysi skin lipid oxid oh radic autoxid reaction human emit nh may also play role nca format chemic process anticip generat aerosol smallest size nm wherea larger cluster result subsequ growth smaller aerosol studi show whenev encount ozon indoor spend live ncas produc air around us | D016902;D010126 | T080;T069;T103 |
34,672,571 | doe optim empow autom prepar enantiomer pure f talazoparib vivo evalu parp radiotrac given clinic potenti poli adp ribos polymeras parp imag detect stratif various cancer develop novel parp imag probe improv pharmacolog profil establish parp imag agent warrant present novel f label parp radiotrac base clinic superior parp inhibitor talazoparib autom radiosynthesi f talazoparib rci n achiev use design experi doe optim copper mediat radiofluorin reaction chiral product isol reaction mixtur use revers phasechir radio hplc ee r f talazoparib demonstr parp bind hcc cell vitro show excel tumor blood ratio xenograft bear mice addit favor pharmacolog profil term excret metabol target engag observ synthesi f talazoparib exemplifi doe enabl radiosynthes synthet challeng radiolabel compound high interest imag communiti | D001331 | T066 |
34,672,569 | beyond bioextract role oyster mediat denitrif nutrient manag recent interest grown use oyster mediat denitrif result aquacultur restor mechan reactiv nitrogen n remov date short term n remov bioextract receiv manag interest grow bodi research shown oyster also mediat long term remov n denitrif microbi convers reactiv n relat inert dinitrogen n gas oyster suspens feed ammonium releas via wast deposit organ matter sediment stimul nitrif denitrif near oyster reef aquacultur site oyster also harbor divers microbi communiti tissu shell promot denitrif thus enhanc n remov addit surfac area oyster reef provid habitat filter feed macrofaun communiti enhanc denitrif denitrif complex biogeochem process difficult convey stakehold complex limit consider inclus oyster mediat denitrif within nutrient manag although oyster mediat denitrif standalon solut excess n load may provid addit manag tool leverag oyster aquacultur habitat restor n mitig strategi provid overview biogeochem process involv oyster mediat denitrif summar could incorpor nutrient manag effort various stakehold | D058440;D010125 | T204;T067 |
34,672,568 | control proton fe lead mitoneet analogu concurr cluster modif mitoneet key regulatori protein mitochondri energi metabol exhibit uniqu ligat fe cluster one histidin three cystein uniqu cluster postul sens redox environ releas fe cofactor acid ph report herein synthet system show fe cluster react proton rearrang coordin geometri low temperatur stabl site differenti cluster fe sph cf coo fe sph py prepar via control proton c character nmr uv vis x ray absorpt spectroscopi complex exhibit anod shift redox potenti compar fe sph convert fe sph upon warm room temperatur current studi provid insight mitoneet releas fe respons high tune acid condit chemistri may implic fe biogenesi | D007506 | T116;T123 |
34,672,565 | near infrar emit phosphor lamg snge cr plant growth applic crystal structur luminesc thermal stabil correspond absorpt curv plant photosensit pigment pfr near infrar light broad applic prospect plant light order explor plant growth lamp novel near infrar emit phosphor lamg sn cr synthes effici excit nm blue light two luminesc center proven test low temperatur spectrum excit spectrum differ wavelength lifetim decay curv two cell sequenc substitut process obtain rietveld refin xrd introduc ge luminesc intens increas time intens c remain almost room temperatur final two differ kind illumin experi plant growth carri feasibl lamg snge cr phosphor plant growth confirm | D049449 | T070 |
34,672,564 | identif apocarotenoid chemic marker vitro anti inflammatori activ spirulina supplement identif chemic marker food addit dietari supplement crucial quantit assess standard qualiti efficaci arthrospira platensi former spirulina platensi known colloqui spirulina wide investig various biolog effect includ anti inflamm antihypertens antioxid antiatherosclerosi studi util approach involv combin bioassay guid fraction synthesi mass spectral molecular network princip compon analysi pca correl analysi identifi measur chemic marker spirulina product use evalu efficaci commerci product downregul express level proinflammatori cytokin interleukin il interleukin il tumor necrosi factor tnf consequ found apocarotenoid hydroxi ionon apo zeaxanthinon ab signific repress express il respect il respect gml p use raw mous macrophag notabl first report isol apocarotenoid spirulina vitro anti inflammatori properti final propos use approach conveni way establish marker dietari supplement | D053545 | T007 |
34,672,563 | ultrahigh pressur facilit acyl malvidin chlorogen acid increas stabil protect effect malvidin deriv h induc arp cell explor effect ultrahigh pressur technolog chlorogen acid color stabil structur activ relationship malvidin mv experiment condit optim singl factor experi respons surfac analysi pressur mpa mass ratio mv chlorogen acid ww time min compar mv mv deriv show higher stabil vitro antioxid activ x ray diffract analysi uv vis spectroscopi fourier transform infrar spectroscopi high perform liquid chromatographi mass spectrometri conduct determin structur mv deriv first time ultrahigh pressur facilit acyl chlorogen acid mv produc four new mv deriv analysi effect malvidin acryl acid hydroxi carboxi cyclohexanol ester guaiacol mvacec arp cell expos h rna transcriptom sequenc show mvacec simultan inhibit various inflammatori apoptot signal transduct pathway exert synergist effect part inhibit cell apoptosi mapk signal pathway therefor result show ultrahigh pressur caus acyl chlorogen acid mv produc four new mv deriv mv deriv protect arp cell h induc oxid stress | D002726;D006861 | T121;T109;T123;T130;T197 |
34,672,562 | synergist health benefit household stove upgrad energi switch rural china rural residenti energi switch solid fuel electr natur gas result substanti health benefit china quantit estim environment health benefit stove upgrad energi switch interact stove upgrad energi switch rural mainland china period driven govern intervent technic progress socioeconom develop domest stove upgrad domin open fire tradit stove energi save clean stove gas rangeelectr stove furthermor stove upgrad signific contribut overal reduct pm emiss ambient indoor pm concentr popul exposur prematur death attribut residenti emiss interact stove upgrad energi switch result addit reduct prematur death influenc residenti sector benefici effect stove upgrad energi switch magnifi along causal path emiss health impact overal benefit transit residenti energi would substanti underestim without consid stove upgrad | D000393;D016902;D006794 | T131;T069;T080;T073 |
34,672,559 | discoveri amino h imidazol carboxamid deriv high select coval bruton tyrosin kinas btk inhibitor bruton tyrosin kinas btk inhibitor suppress aberr activ btk led paradigm shift therapi b cell malign howev urgent need discov select coval btk inhibitor owe target advers effect approv inhibitor ibrutinib herein disclos discoveri preliminari activ studi novel btk inhibitor carri amino h imidazol carboxamid hing binder potent btk inhibitor demonstr impress select favor pharmacokinet properti robust antitumor efficaci vivo indic potenti novel therapeut option b cell lymphoma import best knowledg first exampl amino h imidazol carboxamid scaffold use hing binder kinas inhibitor larg expand chemic divers kinas inhibitor | D055808 | T062 |
34,672,558 | advanc control releas pesticid formul improv efficaci target pesticid common use modern agricultur import global food secur howev postappl loss due degrad photolysi evapor leach surfac runoff process may substanti reduc efficaci control releas formul achiev permeat regul transfer activ ingredi reservoir target surfac thus maintain activ ingredi predetermin concentr specifi period reduc degrad dissip loss potenti improv efficaci recent develop control releas technolog adapt concept intellig precis pharmaceut industri review present recent advanc develop control releas formul discuss detail prepar method materi improv applic technolog | D010575 | T131 |
34,672,557 | shift snow rain midlatitud japan increas fresh submarin groundwat discharg doubl inorgan carbon flux year fresh submarin groundwat discharg fsgd well establish land sea pathway water materi increas along midlatitud coast japan shift snowfal rainfal sinc terrestri deriv fsgd area resid time year materi flux may respond quick effect recent warm studi fsgd collect direct seafloor water depth two differ period observ use consist method evalu warm relat effect fsgd materi flux fsgd system dissolv constitu isotop composit decreas resid time one third compar previous data even though homogen water qualiti maintain among fsgd connect aquif period concern chang result drop ph increas fsgd deriv carbon flux total nutrient flux land rough halv result lower primari product estim doubl excess dissolv inorgan carbon coastal water find present direct evid sensit carbon flux climat chang urgenc carbon relat fsgd research worldwid | D060587;D012914 | T070;T082;T081 |
34,672,556 | bodipi ruthenium ii bis terpyridin complex cellular imag type ii photodynam therapi seri multichromophor ruthenium ii complex formul ru tpi bodipi tpi r cl heterolept ru ii bis tpi tpi phenyl terpyridin moieti coval link boron dipyrromethen bodipi pendant prepar character applic phototherapeut photodetect agent cancer therapi explor ligand l terpyridin bodipi moieti complex pf salt structur character singl crystal x ray diffract studi complex distort octahedr run core ru ii bis terpyridin unit coval link one photoact bodipi unit complex exhibit strong absorb near nm cm high singlet oxygen sensit abil give singlet oxygen quantum yield valu rang dmso emiss base studi use complex singlet oxygen sensor green sosg display format singlet oxygen insid cell also buffer medium upon light irradi dna puc photocleavag experi use ros scavengersstabil reveal photoinduc generat singlet oxygen type ii process superoxid anion radic type process complex pendant biotin moieti cancer cell target group show high photocytotox remark phototherapeut index pi valu hela cancer cell low light dose activ nm j cm complex display reduc activ noncancer hpld cell emiss properti complex use cellular imag thus make suitabl next generat theranost pdt agent | D010778 | T061 |
34,672,548 | discoveri structur base optim fragment bind mix lineag kinas domain like protein execution domain necroptosi form program cell death case misregul lead inflammatori diseas mix lineag kinas domain like protein mlkl effector protein canon necroptosi signal pathway becom activ phosphoryl report identif novel revers binder mlkl execution domain protein nmr detect fragment base screen determin protein fragment costructur use nmr spectroscopi reveal small molecul bind site distinct previous identifi bind site coval mlkl inhibitor affin optim initi priorit hit millimolar affin achiev nmr guid structur base design yield fragment like molecul k furthermor demonstr improv fragment compet bind site nonyl maltosid deterg conjunct phytic acid activ mlkl execution domain | D055808 | T062 |
34,672,547 | compar assess cook emiss contribut urban organ aerosol use onlin molecular tracer aerosol mass spectrometri measur cook organ aerosol coa import sourc particul pollut urban region yet divers complex coa compon make direct identif quantif coa difficult studi conduct colloc oa measur aerosol mass spectromet am thermal desorpt aerosol gas chromatographi mass spectromet tag shanghai cook molecular tracer eg c fatti acid azela acid measur tag provid unambigu sourc inform evalu tracer ion c h z use identif apportion coa am analysi base colloc am tag measur two coa factor name primari coa pcoa oxygen coa ocoa produc rapid oxygen fresh emit pcoa identifi criteria identifi coa factor am analysi differ oxygen level propos ie characterist mass spectra tempor variat etc furthermor two posit matrix factor approach name am pmf molecular marker mm pmf compar coa quantif high consist found contribut coa total pm mass estim am pmf mm pmf studi highlight import impact cook activ air qualiti urban area also demonstr advantag conduct colloc measur use multipl high time resolut mass spectrometr techniqu advanc understand atmospher oa chemistri improv accuraci sourc apportion | D000393;D052638 | T167;T131 |
34,672,546 | reduct hydroxymethylfurfur dicarbonyl compound saccharomyc cerevisia model system beer glycat caramel reaction malt lead format dicarbonyl compound come contact yeast ferment present studi metabol fate hydroxymethylfurfur hmf dicarbonyl compound deoxyglucoson deoxygalactoson deoxypentoson dideoxyglucoson ene assess presenc saccharomyc cerevisia hmf degrad fast yeast format bis hydroxymethyl furan bhmf contrast dicarbonyl compound degrad within h respect deoxyketos deoxyfructos df deoxytagatos deoxypentulos dideoxyfructos identifi metabolit deoxyglucoson convert deoxyfructos deoxypentoson convert deoxypentulos h start parent dicarbonyl compound synthesi deoxyketos metabolit achiev appli metal catalyz reduct presenc molecular hydrogen small set commerci beer sampl bhmf deoxyketos qualit detect df quantit four commerci beer sampl concentr mgl | D001515;D012441 | T004;T168 |
34,672,544 | new fluoresc probe sensit determin glyphos food environment sampl paper dual function probe benzothiazol hydroxi methylphenyl imino phenol bhmh synthes character simultan detect cu fe dimethyl sulfoxid hydroxyethyl piperazineethanesulfon acid dmsohep vv ph limit detect lod cu fe nm respect base competit coordin complex bhmh cu fe exhibit good sensit select glyphos lod bhmh cu bhmh fe glyphos respect probe quantit detect glyphos tap water songhua river water local water soil food sampl colorimetr site glyphos sens probe bhmh cu also studi base smartphon bhmh bhmh cu fe exhibit outstand imag capabl cu fe glyphos live cell low cytotox especi first time glyphos | D003300;D005456 | T130;T121;T196;T123 |
34,672,541 | effect enzymat depolymer cellulos hemicellulos direct dissolut prehydrolysi kraft dissolv pulp prehydrolysi kraft phk pulp account half global market dissolv pulp character high reactiv toward dissolut perform still improv activ treatment studi compar dissolut kinet cupriethylenediamin hardwood softwood phk pulp activ high solid content mechano enzymat treatment three enzym combin test endoglucanas e xylanas mannanas xm endoglucanas xylanas mannanas exm xylanas mannanas reduc hemicellulos content hardwood max mix carbohydr depolymer decreas dissolut time hardwood softwood pulp maximum e xm exm respect shorten dissolut time partial hinder hornif increas hemicellulos degrad interest xm acceler dissolut preserv high weight averag molecular mass | D002480;D002482 | T116;T121;T109;T123;T122;T126 |
34,672,536 | singl neuron rna modif analysi mass spectrometri character rna modif pattern dynam singl cell resolut entir collect post transcript modif rna known epitranscriptom increas recogn critic regulatori layer cellular translat machineri howev contemporari method analysi rna modif limit detect high abund modif bulk tissu sampl potenti obscur uniqu epitranscriptom individu cell popul averag develop approach singl neuron rna modif analysi mass spectrometri snrma ms enabl detect quantif numer post transcript modifi nucleosid singl cell compar convent rna extract approach allow detect rna modif singl cell snrma ms leverag optim sampl prepar approach detect rna modif individu neuron central nervous system aplysia californica snrma ms reveal rna modif profil identifi californica neuron differ physiolog function most cell specif howev function homolog neuron tend demonstr similar modif pattern stabl isotop label cd met show signific differ rna methyl rate depend ident modif cell metacerebr cell mccs display fastest incorpor cd group endogen rnas quantit snrma ms show higher intracellular concentr methyladenosin methylcytidin homolog rlpl cell pair mccs overal snrma ms first analyt approach capabl simultan quantifi numer rna modif singl neuron reveal cell specif modif profil | D009474;D012313 | T025;T114 |
34,672,535 | character inhibit deoxi xylulos phosphat reductoisomeras promis drug target acinetobact baumannii klebsiella pneumonia eskap pathogen compris group multidrug resist bacteria lead caus nosocomi infect worldwid preval antibiot resist strain relat eas bacteria acquir resist gene highlight continu need develop novel antibiot new drug target methylerythritol phosphat mep pathway attract target develop new antibiot mep pathway govern synthesi isoprenoid key lipid precursor vital cell compon ubiquinon bacteri hopanoid addit mep pathway entir distinct correspond mammalian pathway mevalon acid mva pathway make first commit enzym mep pathway deoxi xylulos phosphat reductoisomeras ispc attract target antibiot develop facilit drug develop two eskap pathogen acinetobact baumannii klebsiella pneumonia clone express purifi character ispc two gram negat bacteria enzym inhibit assay use ispc two pathogen compound fosmidomycin fr indic ic valu rang nm antimicrobi suscept test inhibitor reveal baumannii suscept fr wherea k pneumonia suscept compound final facilit structur base drug design inhibitor target baumannii ispc determin crystal structur ispc baumannii complex inhibitor fr cofactor nadph magnesium | D040981;D019747;D004364 | T007;T116;T126;T121 |
34,672,533 | sustain adenosin receptor antagonist drug releas nanoparticl function neural trace protein respiratori dysfunct major caus death peopl spinal cord injuri sci remain unsolv problem treat sci intoler side effect drug patient signific departur convent target nanotherapeut overcom blood brain barrier bbb work pursu drug deliveri approach use neural trace retrograd transport protein bypass bbb deliv adenosin receptor antagonist drug dipropyl cyclopentyl xanthin exclus respiratori motoneuron spinal cord brainstem singl intradiaphragmat inject one thousandth nativ drug dosag induc prolong respiratori recoveri hemisect anim model translat discoveri new treatment respiratori dysfunct carri studi character puriti qualiti synthesi stabil drug releas properti neural trace protein wheat germ agglutinin chemic conjug horseradish peroxidas coupl nanoconjug show batch batch particl size drug dosag variat less evalu nanoconjug size spatial constraint impos transsynapt transport pre postsynapt neuron determin nanoconjug formul capabl sustain drug releas last day physiolog ph prerequisit long distanc transport drug diaphragm muscl brainstem model drug releas profil use first order reaction model noy whitney diffus model confirm via biolog electron microscopi nanoconjug particl accumul tissu inject site defin nanoconjug storag condit monitor solut dispers stabil various condit month studi support develop neural trace protein enabl nanotherapeut treat respiratori problem associ sci | D004364;D013119 | T121;T037 |
34,672,530 | cowpea mosaic virus nanoparticl vaccin candid display peptid epitop neutral sever acut respiratori syndrom coronavirus develop vaccin coronavirus focus spike protein requir recognit host cell receptor thus elicit neutral antibodi target conserv epitop protein offer potenti pan beta coronavirus vaccin could prevent futur pandem display five b cell epitop origin identifi convalesc sera recov sever acut respiratori syndrom sar patient surfac cowpea mosaic virus cpmv evalu formul vaccin prime boost immun mice three candid vaccin cpmv cpmv cpmv elicit high antibodi titer neutral sever acut respiratori syndrom coronavirus sar cov vitro show earli th bias profil week transit slight th bias profil second boost week pentaval slow releas implant compris five peptid display cpmv elicit anti protein epitop specif antibodi titer albeit lower magnitud compar solubl formul cpmv remain intact releas plga implant process result loss rna act adjuv loss rna may reason lower efficaci implant final although three epitop found neutral sar cov ident sar cov none vaccin candid neutral sar cov vitro suggest differ natur epitop perhap caus conform chang presenc n link glycan cross protect vaccin candid develop multival sar vaccin develop technolog discuss versatil vaccin platform pivot toward diseas applic limit infecti diseas | D000086382;D017798;D053758;D014612 | T116;T047;T121;T073;T129;T005;T067 |
34,672,529 | n dope graphen aerogel multifunct air cathod microbi fuel cell one main challeng face microbi fuel cell mfcs generat voltag facilit oxygen reduct reaction orr process use specif design air cathod especi optim three phase catalyt interfac enhanc diffus herein three dimension porous n dope graphen aerogel nga polymer onto steel mesh sm construct simpl structur air cathod nga xsm via hydrotherm synthesi subsequ freez dri treatment specif nga simultan use effici orr catalyst layer breathabl gas diffus layer improv perform mfcs system nga sm precursor concentr x mg ml make perfect candid use air cathod character paramet reveal sub micromet micropor defect multilay structur highest proport pyridin n exist nga sm furthermor electrochem measur demonstr oxygen reduct peak potenti v tafel slope mv dec closest e transfer pathway n data prove three phase boundari natur form nga sm orr occur import work provid proof concept pt free air cathod could prepar high effici nga two step prepar method achiev mfc maximum power densiti mw | D001674 | T074;T073 |
34,672,528 | fabric magnet fluorin coval organ framework select captur benzoylurea insecticid residu beverag effici captur benzoylurea insecticid bu residu food vital procedur food safe monitor herein core shell structur magnet fluorin coval organ framework good magnet respons abund fluorin affin site success synthes suitabl magnet solid phase extract mspe bus use room temperatur synthesi strategi magnet fluorin coval organ framework fabric situ polymer tris aminophenyl triazin tapt tetrafluoroterephthaldehyd tfta surfac carboxyl fe nanoparticl competit adsorpt experi molecular simul verifi magnet fluorin coval organ framework possess favor adsorpt affin bus magnet fluorin coval organ framework could easili regener reus least eight time reduct enrich perform combin magnet fluorin coval organ framework base mspe high perform liquid chromatographi tandem mass spectrometri novel sensit method analysi bus develop yellow wine fruit juic sampl good linear correl obtain bus rang ngl respect limit quantit bus rang ngl two beverag matric desir precis achiev intraday interday relat standard deviat lower | D005504;D052616 | T059 |
34,672,526 | aryl transfer strategi mediat photoinduc electron transfer radic aryl migrat power techniqu forg new bond aromat compound grow popular photoredox catalysi led influx novel strategi initi control aryl migrat start wide avail radic precursor review encapsul progress radic aryl migrat enabl photochem methodsparticular photoredox catalysissinc special attent paid descript scope mechan synthet applic method | D004583 | T196;T081 |
34,672,523 | develop singl quantum dot mediat fret nanosensor sensit detect singl nucleotid polymorph cancer cell singl nucleotid polymorph snps import hallmark human diseas herein develop singl quantum dot qd mediat fluoresc reson energi transfer fret nanosensor integr multipl primer generat roll circl amplif mpg rca sensit detect snps cancer cell assay involv linear padlock probe mpg rca presenc mutant target facilit circular linear padlock probe initi rca produc three short singl strand dnas ssdnas assist nick endonucleas result ssdnas function primer induc cyclic mpg rca result exponenti amplif generat larg number linker probe linker probe subsequ hybrid cy label report probe biotinyl captur probe obtain sandwich hybrid assembl sandwich hybrid nm emiss quantum dot qd generat qd oligonucleotid cy nanostructur result effici fret qd cy nanosensor free complic probe design exogen primer distinct advantag high amplif effici zero background signal good specif high sensit detect snps larg dynam rang order magnitud detect limit moreov nanosensor accur distinguish low mutat level mixtur achiev previous report method furthermor discrimin cancer cell normal cell even quantifi snp singl cell level | D009369;D045663 | T191;T073 |
34,672,522 | bio inspir extend gate metal oxid semiconductor field effect transistor high sensit amino acid enantiodiscrimin import small molecul reveal origin life amino acid aa play essenti role live organ facil enantiodiscrimin long great challeng analyt chemist inspir specif stereomatch effect biomolecul aa enantiom herein first develop bio inspir high sensit platform base extend gate metal oxid semiconductor field effect transistor eg mosfet high sensit aa enantiodiscrimin bovin serum albumin bsa self assembl deposit au surfac afford extend gate eg sens unit enantiorecognit abil initi verifi use common electrochem techniqu eg thereaft instal mosfet build desir bsa eg mosfet high sensit chiral sens platform realiz effici enantiodiscrimin essenti aa high sensit effect chiral resolut achiev femtomol level phenylalanin phe combin molecular dock circular dichroism spectroscopi weak intermolecular interact bsa aa enantiom investig mechan signal amplif propos result demonstr fabric biosensor great potenti high sensit chiral sens field also afford potenti tool biomolecular interact investig | D000596;D015374 | T116;T121;T123;T075;T059 |
34,672,519 | design perform soft land instrument fragment ion deposit report develop new high flux electrospray ionize base instrument soft land mass select fragment ion onto surfac collis induc dissoci perform collis cell posit dual electrodynam ion funnel assembl high duti cycl instrument enabl high coverag deposit mass select fragment ion onto surfac defin kinet energi capabl facilit investig reactiv gaseous fragment ion condens phase demonstr observ reaction deposit fragment ion depend structur ion composit either ionic neutral speci codeposit onto surfac newli develop instrument provid access high puriti ion fragment build block prepar uniqu ionic layer | D005740;D021241 | T104;T059 |
34,672,514 | fabric wearabl flexibl sweat ph sensor base ser activ autpu electrospun nanofib develop wearabl sens platform essenti advanc continu health monitor point care test eccrin sweat ph analyt noninvas measur use diagnos aid monitor wide rang physiolog condit surfac enhanc raman scatter ser offer rapid optic techniqu fingerprint biomark present sweat paper mechan flexibl nanofibr ser activ substrat fabric combin electrospin thermoplast polyurethan tpu au sputter coat substrat investig suitabl toward wearabl sweat ph sens function two common use ph respons molecul mercaptobenzo acid mba mercaptopyridin mpi develop ser ph sensor found good resolut ph unit mba ph unit mpi l sweat requir measur display statist signific differ perform day p addit autpu nanofibr ser ph sensor show fast sweat absorb abil well good repeat revers propos methodolog offer facil rout fabric ser substrat could also use measur wide rang health biomark beyond sweat ph | D015374;D000076251 | T059;T073;T075 |
34,672,512 | adapt escherichia coli biofilm growth morpholog mechan properti substrat water content biofilm complex live materi form bacteria becom embed matrix self produc protein polysaccharid fiber addit tradit associ chronic infect clog pipelin biofilm current gain interest potenti sourc function materi nutrit hydrogel micron size escherichia coli cell build centimet larg biofilm process bacteri prolifer matrix product water uptak introduc mechan stress biofilm releas format macroscop delamin buckl third dimens clarifi substrat water content could use tune biofilm materi properti quantifi e coli biofilm growth delamin dynam rigid function water content nutrit substrat time laps microscopi comput imag analysi reveal softer substrat high water content promot biofilm spread kinet stiffer substrat low water content promot biofilm delamin delamin buckl observ biofilm cross section appear bent substrat high water content tend vertic substrat low water content wet dri biomass accumul day cultur larger biofilm cultur substrat high water content despit extra poros within matrix layer final microindent analysi reveal substrat low water content support format stiffer biofilm studi show e coli biofilm respond substrat water content might use tune materi properti view applic | D004926;D014867 | T007;T121;T197 |
34,672,511 | cross section studi birth prepared complic readi amongst pregnant women attend ant natal clinic tertiari hospit birth prepared complic readi bpcr key compon safe motherhood program reduc matern mortal promot activ prepar decis make deliveri pregnant women famili | D007744;D037841 | T046;T098 |
34,672,509 | epidemiolog suicid suicid behaviour across lifespan nigeria systemat review literatur suicid behaviour global public health issu affect age gender region world systemat review sought synthes avail evid preval risk factor suicid suicid behaviour across lifespan nigeria | D008136;D059020 | T033;T079;T102 |
34,672,486 | impact direct act antivir daa neurolog disord chronic hepat c neurolog neuropsychiatr manifest sometim provid first evid unknown hcv infect condit develop variabl rang morbid includ brain fog fatigu subtl cognit attent impair also sever complic acut present like encephalomyel encephalopathi stroke peripher nerv involv | D006528;D019698;D008113;D009422 | T191;T047 |
34,672,485 | profil abdomin aortic aneurysm growth three dimension ultrasound profil new method base three dimension ultrasound us allow direct comparison baselin follow diamet along aaa length studi aim evalu feasibl profil visual aaa chang submaximum diamet categor growth profil | D017544 | T047 |
34,672,484 | efficaci bioactiv anticalculus toothpast oral health singl blind parallel group clinic studi current epidemiolog studi confirm widespread presenc calculus teenag adult age among multipl anticalculus strategi propos year inhibit crystal growth attract current formul anticalculus toothpast mothwash util either hydroxyapatit various pyrophosph combin studi aim analyz efficaci anticalculus tooth past combin mouth rins | D009909;D014100 | T033;T122 |
34,672,483 | express survivin oral leukoplakia oral lichen planus one third oral squamous cell carcinoma develop potenti malign lesion common potenti malign lesion pml leukoplakia lichen planus import diagnos pml earli stage prevent malign transform lesion survivin smallest member inhibitor apoptosi iap famili protein survivin play import role apoptosi regul high express survivin earli event oral carcinogenesi act tool identif precancer lesion higher risk progress invas carcinoma aim studi evalu express survivin oral leukoplakia oral lichen planus | D006258;D017676;D009062 | T191;T047 |
34,672,482 | tiger nut antidot alcohol induc testicular toxic male spragu dawley rat studi implic alcohol consumpt factor lead male infertil tiger nut cyperus esculentus hand shown possess potenti boost male reproduct indic studi carri investig effect tiger nut alcohol induc testicular toxic male spragu dawley rat | D000931;D013737 | T023;T121 |
34,672,476 | efficaci hemoporfin photodynam therapi puls dye laser resist facial port wine stain children retrospect studi port wine stain occur newborn main face neck puls dye laser recogn gold standard treatment nevertheless associ low cure rate high recurr rate | D010778 | T061 |
34,672,471 | consid role context implement govern polici hospit introduct prospect payment system psychiatri context innov implement import often neglect mediat chang prospect payment system pps psychiatr psychosomat facil major implic inpati psychiatr care germani implement studi aim examin determin implement govern polici use diffus innov theori consid role context | D011445;D011570 | T097;T170;T091;T081;T058 |
34,672,470 | ultra fast respons polym optic fiber oxygen measur devic preliminari experiment report continu dynam chang arteri oxygen partial pressur mechan ventil live anim object tri implant ultra fast polym optic fiber chemic oxygen sensor pofco arteri blood vessel connect photoelectr convers measur system record continu dynam rapid chang arteri po pao whole live anim experiment evid new theori holist integr physiolog medicin hipm forexplain mechan respiratori control regul whole circusof respir circul metabol method fabric ultrafast pofco calibr measur system distal part optic fiber heat pull becam taper tip clean dri tip mm taper optic fiber dip coat luminophor dope polym solut slowli pump solvent quick evapor form oxygen sens tip dri room temperatur hour anim experi general anesthesia intub goatwa mechan ventil oxygen expos right left carotid arteri left femor arteri skin cut insert pofco direct arteri via indwel cathet end pofco connect person comput optic fiber excit detect type optic fiber coupler photoelectr convers realiz continu dynam respons live goat carotid pao mechan ventil main analyz intra breath wave form altern increas decreas pao time delay lung carotid arteriesw complet breath control whole loop explain mechan mutual breath switch inspir exhal result pofco fast respons time set ms liquid heart rate oxygen mechan ventil live goat bpm pao left right carotid arteri show wave sizeup follow inspir expir ventil rang mmhg weresignific nois pao chang record left femor arteri lung carotid arteri time delay inhal exhal pao left right carotid arteri start toincreas decreas two three heartbeat start lung ventil thealtern wave form inform arteri pulmonari vein blood pulmonari capillari waspumpedbi left ventricl posit peripher chemoreceptor thus realiz whole cycl inhal exhal altern interrupt inhal ie switch inhal exhal interrupt exhal ie switch exhal inhal conclus ultra fast reactiv implantableoxygen sensor measur system measur physiolog waveform chang pao live anim provid experiment evid explain mechan switch inspir expir hipm | D011108;D012121 | T104;T122;T061 |
34,672,469 | clinic observ research use precis electromagnet power meter arm dynamomet upper limb evalu holist function cardiopulmonari metabol object subject use upper limb arm dynamomet lower limb precis electromagnet power meter cycl ergomet perform symptom restrict limit cardiopulmonari exercis test cpet analyz clinic valu arm ergomet cpet method upper limb lower limb precis electromagnet power meter use complet cpet two differ day normal peopl chronic patient analyz cpet data calcul relat core indic compar normal subject chronic patient analyz similar differ upper lower extrem correl result compar patient chronic diseas signific differ age vs year diagnosi normal peopl peak hr vs bpm p peak v vs l peak vs lmin lower limb cpet signific higher upper limb p signific differ peak bf upper limb cpet use ex time vs min shorter lower limb cpet peak work rate vs wmin peak vo vs lmin vs lmin peak vo hr vs mlbeat ouep vs lower lowest vevco vs vevco slope vs higher lower limb cpet p comparison result two subgroup normal chronic patient holist comparison result ex time peak hr peak bf peak vt peak upper limb cpet good correl result lower limb cpet besid measur valu percentag project valu peak work rate measur valu kilogram weight valu peak vo percentag project valu peak vo measur valu peak vo hr also good correl measur valu ouep measur valu percentag project valu lowest vevco vevco slope also indic signific correl conclus supplement lower limb cpet upper limb cpet high feasibl safe holist function status assess provid import supplement guid implement holist plan individu precis exercis worthi explor | D001132;D006333 | T047;T029;T046 |
34,672,468 | impact outpati vs inpati holist manag base exercis train cardiac rehabilit efficaci among patient chronic heart failur object evalu impact outpati vs inpati exercis train et cardiac rehabilit efficaci among patient chronic heart failur chf method thirti six patient diagnos chf beij rehabilit hospit septemb septemb random divid three group control group n outpati et group n inpati et group n patient control group treat convent cardiac rehabilit without et patient outpati inpati et group treat holist cardiac rehabilit core et accord individu exercis prescript base cardiopulmonari exercis test cpet exercis intens cycl ergomet power anaerob threshold mind dweek week general inform cpet paramet echocardiogram minut walk distanc mwd qualiti life qol score three group patient treatment record result patient group finish symptom limit cpet patient et group finish week et safe without complic treatment signific differ cpet paramet echocardiogram result mwd qol score among group p treatment mlmin ml minkg pred peak oxygen uptak vo mlmin ml minkg pred peak oxygen puls mlbeat peak workload wmin pred left ventricular eject fraction lvef mwd patient outpati inpati et group signific higher patient control group p qol score patient outpati inpati et group lower patient control group p mlmin ml minkg peak vo mlmin ml minkg pred peak oxygen puls mlbeat pred peak workload wmin pred lvef mwd patient outpati inpati et group signific higher treatment p qol score patient outpati inpati et group treatment signific lower treatment p conclus outpati et improv cardiopulmonari function exercis toler qol chf patient signific differ compar inpati et indic outpati cardiac rehabilit effect rehabilit mode deserv appli wide | D000072038;D006333 | T047;T061;T046 |
34,672,467 | cardiopulmonari exercis test cpet evalu efficaci intens control person precis exercis train cardiovascular cerebrovascular chronic diseas object studi symptom restrict extrem cardiopulmonari exercis test cpet evalu improv overal function patient long term chronic diseas intens control person precis exercis train month method select patient chronic cardiovascular cerebrovascular metabol diseas intens control team sign inform consent form base result cpet continu function test formul overal manag plan individu moder exercis intens core month cpet perform chang cpet indic intens control patient analyz individu differ valu percentag differ valu calcul result studi patient male femal chronic cardiovascular cerebrovascular metabol diseas age year height cm weight kg patient danger event period cpet intens controlaft intens control static pulmonari function index rest systol blood pressur rate blood pressur product fast blood glucos signific improv p intens control peak oxygen uptak pred anaerob threshold pred intens control peak oxygen uptak pred anaerob threshold pred compar intens control peak oxygen uptak anaerob threshold patient intens control signific increas p core index also improv signific includ peak oxygen uptak peak heart rate peak work rate oxygen uptak effici plateau lowest valu carbon dioxid ventilatori effici slope ventilatori equival carbon dioxid ramp exercis durat p conclus cpet safe object quantit evalu overal function status therapeut effect guid formul individu precis exercis intens overal plan individu precis exercis three month safe effect revers overal function status patient long term cardio cerebrovascular metabol diseas | D005080;D010101 | T060;T201 |
34,672,466 | clinic studi diagnost valu cardiopulmonari exercis test coronari atherosclerot heart diseas object evalu valu cardiopulmonari exercis test diagnos coronari atherosclerot heart diseasechd method total patient suspect chdthe patient condit relat stabl age yearswer perform cardiopulmonari exercis test ecg exercis test coronari angiographi base result coronari angiographi sensit specif diagnost valu relev indic cardiopulmonari exercis test cpet paramet peak vo predpeak puls predvo wr diagnos chd analyz statist method base result coronari angiographi result use best cut point peak vo pred detect chd sensit specif auc sensit specif auc peak puls pred respect vo wr sensit diagnos chd specif auc sensit peak puls pred vo wr much higher ecg exercis test differ statist signific p conclus sensit index cpet diagnos chd better ecg exercis test specif diagnost valu optim cut point high cpet predict valu diagnosi chd diagnos chd earli accur | D003327;D005080 | T047;T060 |
34,672,465 | characterist core paramet cardiopulmonari exercis test patient hypertrophi cardiomyopathi object patient hypertroph cardiomyopathi hcm character hypertrophi myocardium high risk sudden death less clear exercis pathophysiolog guidanc holist integr physiolog medicin hipm ramp protocol symptom limit cardiopulmonari exercis test cpet method evalu overal function status human bodi investig cpet pathophysiolog patient hcm method april januari subject enrol sign inform consent form complet cpet fuwai hospit hcm patient healthi normal subject control ns chang cpet core paramet two calcul compar individu analysi result gender hcm maleand femal gender ns male femal age hcm year ns yearth core cpet paramet hcm peak oxygen uptak peak vo pred anaerob threshold pred peak puls pred oxygen uptak effici platform ouep pred lowest vevco pred vevco slope pred compar ns peak vo peak puls ouep signific decreas p p lowest vevco vevco slope signific increas p individu analysi overal function status cpet sever hcm still within normal rang peak vo posit correl ouep peak puls peak systol blood pressur negat correl lowest vevco vevco slope conclus cpet safe specif characterist patient hcm deserv research clinic applic hipm guidanc cpet use overal function evalu diseas diagnosi differenti diagnosi risk stratif curat effect evalu accur prognost predict also util formul individu train prescript manag chronic diseas | D002312;D006333 | T047;T046 |
34,672,464 | result analysi pulmonari function examin case physic examin crowd henain provinc object pulmonari function test pft electrocardiograph ecg vital compon cardiopulmonari exercis test cpet studi investig clinic characterist abnorm pft pulmonari ventil dysfunct small airway dysfunct gas exchang diffus dysfunct method across section studi conduct outpati subject receiv health examin decemb februari henan provinci peopl hospit recruit result ecg pft compar among differ sex age sub group sever impair pft analyz result among subject subject male subject femal total patient abnorm ecg total patient abnorm pulmonari ventil function patient male patient femal number percentag abnorm pulmonari ventil function male signific femal p percentag detect rate male signific higher femal differ age sub group year p total detect abnorm rate small airway dysfunct male signific higher femal x p detect abnorm rate small airway dysfunct male lower femal year year sub group p signific higher yr sub group p abnorm gas exchang diffus dysfunct detect subject male femal signific gender differ p abnorm diffus detect rate year sub group signific higher femal male p signific lower femal male year sub group p conclus abnorm detect rate ecg pulmonari ventil dysfunct gas exchang dysfunct small airway dysfunct higher male femal higher elder year subgroup younger age subgroup | D005080;D008168 | T023;T060 |
34,672,463 | primari clinic investig cardiopulmonari exercis gas exchang pulmonari hypertens patient without right left shunt object aim studi determin chang gas exchang paramet ramp increment cardiopulmonari exercis test cpet patient pulmonari hypertens ph could identifi right left shunt r l shunt method retrospect analysi exercis gas exchang paramet ph patient normal subject control fuwai hospit octob august cpet signatur content form gas exchang data cpet doubl blind independ interpret four export doctor accord read result cpet ph patient divid four group r l shunt posit group r l shunt suspici group r l shunt negat group late open r l shunt posit group result minut ventil ventilatori equival carbon dioxid oxygen vevco vevo end tidal partial pressur oxygen peto r l shunt posit group signific increas lmin mmhg begin exercis also signific higher control lmin mmhg partial pressur carbon dioxid end expiratori gas petco decreas mmhg signific lower control mmhg p respiratori quotient rer carbon dioxid vevco vevo peto late open r l shunt posit group sudden increas mmhg end exercis near peak signific higher control mmhg petco sudden decreas end exercis compar rest stage mmhg signific differ control mmhg carbon dioxid ventilatori effici oxygen uptak ventilatori effici relat peak power recoveri stage late open r l shunt posit group signific lower control p conclus cardiopulmonari function ventil effici patient withpulmonari hypertens signific decreas pulmonari hypertens right left shunt patient rest ventil effici limit serious characterist r l shunt sudden increas peto vco rer sudden decreas petco vo begin exercis common compani decreas spo delay open r l shunt chang occur near peak exercis rather begin characterist chang quick revers stop exercis | D006976 | T046 |
34,672,462 | preliminari experiment studi influenc differ tidal volum frequenc normal minut ventil dynam chang carotid blood oxygen live goat object basi preliminarili verifi use ultra fast reaction polym matrix optic fiber oxygen sensor measur system record continu dynam chang carotid arteri oxygen partial pressur pao order analyz discuss influenc lung ventil continu dynam chang pao design whole anim experiment studi vivo method four hybrid goat select skin cut expos direct general anesthesia tracheal intub oxygen sensor connect measur system insert direct left carotid arteri continu record dynam chang pao normal minut ventil mechan ventil implement three tidal volum normal tidal volum vt mlkg rf bpm half tidal volum halv vt doubl rf doubl tidal volum doubl vt halv rf tidal volum stabl min respect analyz calcul averag valu pao fluctuat magnitud pao chang breath last delay time lung carotid arteri analyz effect differ tidal volum result heart rate blood pressur live goat maintain stabl mechan ventil experi normal ventil volum lung carotid arteri delay time heartbeat time normal tidal volum mechan ventil averag valu pao mmhg fluctuat rang mmhg account averag valu condit halv tidal volum averag valu pao maintain mmhg slight decreas signific p compar normal mechan ventil fluctuat rang pao signific reduc mmhg account averag valu doubl tidal volum mechan ventil although averag valu pao increas slight remain mmhg p compar normal mechan ventil p compar half tidal volum mechan ventil fluctuat magnitud pao increas signific mmhg conclus inspir expir normal lung ventil initi factor increas decreas pao carotid arteri normal ventil halv tidal volum doubl tidal volum signific chang fluctuat magnitud pao averag valu pao chang slight lung carotid delay time similar | D006041;D010100 | T015;T121;T196;T123 |
34,672,461 | effect differ respir model amplitud waveform inform arteri blood gas object object find characterist arteri blood sampl waveform differ respir model method six post oper patient normal heart function negat allen test male femal year kg left ventricular eject fraction lvef place arteri catheter central venous catheter continu collect arteri differ kind respir model normal breath breath deep breath select two breath cycl waveform patient data calcul magnitud time interv compar adjac highest lowest valu patient verifi whether period wave like signal chang arteri venous blood gas three breath state addit statist test analysi perform chang amplitud period wave like signal patient arteri venous blood gas compar whether differ result heart beat number draw blood pipe cover breath cycl signific chang arteri pao ie highest high valu compar next lowest valu p three differ breath model normal breath high breath magnitud mmhg mmhg mmhg mean respect po venous blood gas show wavi chang normal breath breath hold high tidal volum ventil amplitud mmhg mmhg mmhg respect signific lower arteri blood gas state signific differ group conclus continu beat beat arteri blood sampl abg analyz method three differ breath model obtain clear evid biggest period paramet abg waveform high breath model follow normal breath model breath smallest wave variat amplitud venous oxygen partial pressur obvious three respiratori state impli oscillatori inform arteri blood come gas exchang lung | D012119;D016277 | T039;T042 |
34,672,460 | experiment evid waveform inform arteri blood gas beat beat sampl method human bodi differ waveform inform arteri venous blood sampl object arteri blood oscillatori inform come right heart system gas exchang lung howev evid waveform venous abg lack object articl compar differ inform arteri venous beat beat blood sampl time method six post oper patient normal heart function negat allen test place arteri catheter central venous catheter direct connect pre heparin plasticpip continu collect arteri venous blood twist pipe helix format draw arteri venous blood syring one heart beat one helix time total heart beat clip pipe forcep put helix pipe icedwat analys pao paco ph sao soon possibl select two breathscycl waveform patient data calcul magnitud time interv result heart beat number draw blood pipe cover breath cycl signific chang arteri pao ie highest high valu compar next lowestvalu p magnitud chang pao arteri venous blood sampl mmhg mmhg signific varianc p mean signific varianc p respect conclus continu beat beat arteri venous blood sampl abg analyz method time obtain clear evid period paramet abg waveform follow breath cycl clear abg waveform period paramet venous blood sampl impli oscillatori inform arteri blood come gas exchang lung | D001158;D018594 | T016;T023 |
34,672,459 | two type exercis induc abnorm blood pressur respons hypertroph cardiomyopathi object insufci exercis blood pressur respons blunt abpr lower blood pressur recoveri period lbp exercis common abnorm patient hypertroph cardiomyopathi hcm purpos studi analyz relat factor two type abnorm blood pressur respons hcm patient relationship cardiopulmonari function method total consecut hcm patient underw cpet fuwai hospit recruit april jan complet clinic assess includ electrocardiographi holter rest echocardiographi cardiac mri one hundr eleven healthi age gender match volunt enrol control group result incid blunt abpr lbp hcm patient much higher normal control group vs p vs p respect hcm group patient blunt abpr combin coronari arteri diseas cad p pulmonari hypertens ph p atrial fibrillationflutt p compar patient without blunt abpr compar hcm patient without lbp patient lbp higher rest left ventricular outflow tract lvot gradient p left ventricular eject fraction p incid lvot obstruct p systol anterior motion p logist regress analysi cad ph independ factor blunt abpr lbp independ associ rest lvot gradient blunt abpr associ lower peak vo peak heart rate hear rate reserv higher nt probnp p vevo p lbp associ index cardiopulmonari function conclus incid blunt abpr lbp hcm patient much higher normal control group hcm patient cad ph independ determin blunt abpr lbp independ associ rest lvot gradient patient blunt abpr lower cardiopulmonari function lbp associ cardiopulmonari function | D002312;D005080 | T047;T060 |
34,672,458 | individu analysi puls wave shape characterist singl precis power exercis young healthi subject object observ studi rest radial arteri puls wave puls wave chang singl individu exercis young healthi normal subject method select young healthi graduat student advanc train doctor visit scholar fuwai hospit without diseas diagnosi low daili exercis first complet symptom restrict limit cardiopulmonari exercis test cpet singl individu exercis power exercis intens complet within one week cpet measur record puls wave data exercis min min min exercis let instrument automat fix point manual recheck obtain puls wave characterist point start point b main wave peak point p trough repuls point pl crest repuls point p end point e raw data abscissa time ordin amplitud correspond point deriv instrument treat end point e previous puls wave start point b next wave return tb zero got main observ indic yb yp ypl yp tp tpl tp te calcul yp yp yb ypl ypl yb yp yp yb te tpl te tpl tpl puls rate slope main wave ascend branch slope dicrot ascend branch yp ypl tp tpl secondari observ indic defin dicrot wave obvious crest yp ypl calcul occurr rate dicrot wave obvious crest number waveform yp ypl total number waveform analyz individu puls wave data subject exercis averag data overal analysi result healthi young subject male femal age year old height cm bodi mass kg yb yp ypl yp tp tpl tp te yp ypl yp te tpl te tpl tpl puls rate yp ypl tp tpl min exercis ypl vs yp vs ypl vs yp vs te vs te tpl vs te tpl tpl vs decreas puls rate vs yp ypl vs tp tpl vs increas p trend puls wave chang min min exercis consist min exercis min indic gradual recov rest level exercis incid dicrot wave obvious peak young healthi person rest increas min min min exercis p among incid dicrot wave obvious peak exercis maintain subject appear rate case reach exercis decreas minut exercis continu increas minut recov three subject low rest rate start increas exercis case rate low minut exercis consid influenc human factor conclus influenc exercis puls wave normal peopl main reflect dicrot wave whole singl precis power exercis posit dicrot wave reduc amplitud deepen appear rate dicrot wave obvious crest general increas chang maintain least minut individu point view respons trend subject differ | D015444;D005080 | T061;T060;T056 |
34,672,457 | preliminari report partial pressur chang oxygen carbon dioxid umbil arteri vein first breath chines neonat ii person analysi partial pressur oxygen carbon dioxid differ umbil arteri vein time newborn object order explor mechan neonat spontan breath differ oxygen carbon dioxid umbil cord arteri vein start spontan breath birth analyz among peopl part relat inform analyz individu method fetal parent sign inform consent birth newborn born breath umbil cord expos quick possibl heparin arteri indwel needl insert umbil arteri umbil vein direct newborn placenta blood taken continu although dozen mother select case collect pua puv blood sampler time blood gas analysi determin differ dynam chang umbil vein umbil arteri calcul analyz result none spontan breath newborn puvo signific higher puao time p averag differ mmhg puvco signific lower puaco p averag differ mmhgthe differ puv uao signific higher puv uaco p conclus puao decreas gradual time heartbeat frequenc spontan breath deliv fetus newborn induc first inhal start spontan breath reach threshold trigger breath | D002245;D014469 | T018;T197;T123 |
34,672,456 | preliminari report partial pressur chang oxygen carbon dioxid umbil arteri vein first breath chines neonat group differ partial pressur oxygen carbon dioxid umbil arteri vein newborn object fetus actual respir newborn begin breath birth assum first breath domin generat hypoxia studi chang lowest limit blood oxygen partial pressureof umbil arteri puao chemoreceptor analyz explor mechan neonat spontan breath method sign consent form fetal parent birth newborn success complet umbil arteri vein catheter drawn blood accord heartbeat blood sampl analyz blood gas analyz calcul analyz similar differ umbil vein puv umbil arteri pua result although complet newborn case umbil arteri sampl case umbil vein sampl collect case collect pua puv blood sampl time see serial paper ii puao gradual decreas time heartbeat frequenc pua contract spontan breath produc heartbeat could get enough blood sampl newborn abl take blood sampl spontan breath heartbeat puao jump mmhg respect mean valu puao mmhg highest valu mmhg lowest valu mmhg although puvo decreas gradual time heartbeat also show tendenc altern rise fall regular mother respir mean valu puvo mmhg highest valu mmhg lowest valu mmhg although larg individu differ mean highest lowest valu puvo signific higher puao p conclus puao decreas gradual time spontan breath deliv fetus newborn induc first inhal start spontan breath reach threshold trigger breath | D002245;D014469 | T018;T197;T123 |
34,672,455 | scienc anatomi art revisit leonardo da vinci pioneer modern anatomi leonardo da vinci artist scientist archetyp figur renaiss era autodidact polymath natur scienc engin physic scienc imbu univers prodigi invent imagin curios know understand world around among myriad activ anatomi physiolog biomechan musculoskelet system under system fulli engag leonardo dissect dozen human anim corps studi anatom illustr precis combin art scienc impecc integr multipl draw diagram sketch design found note leonardo style intens person unveil thought passion emot analyz signific biograph aspect leonardo life remark scientif life concept manifest anatom design contribut preced anatomist report sourc inspir well motiv successor leonardo da vinci left public rather extens collect person notebook leonardo contribut modern anatomi enorm consid scientif medic communiti father modern anatomi | D018594 | T016;T023 |
34,672,450 | oral iron absorpt test simpl test relev clinic set iron defici anemia widespread problem although oral intraven therapi avail iron malabsorpt distinct possibl | D000284;D018798;D005296 | T047;T104;T061 |
34,672,449 | natur anti endotheli cell antibodi patient undergo coronari angiographi anti endotheli cell antibodi aeca known biomark endotheli dysfunct damag clinic practic especi autoimmun diseas | D017023;D003324;D004730 | T047;T024;T060 |
34,672,448 | autonom nervous system indic patient system sclerosi without overt cardiac diseas system sclerosi ssc connect tissu diseas may affect heart autonom nervous system an littl knowledg regard degre an involv ssc patient unknown cardiac diseas | D001342;D006331;D006339;D011681;D012025;D012595 | T047;T039;T042;T190;T019;T037;T201;T060;T033 |
34,672,447 | acpa antibodi titer time rheumatoid arthriti diagnosi associ diseas sever rheumatoid arthriti ra chronic inflammatori destruct joint diseas presenc autoantibodi rheumatoid factor rf anti citrullin protein antibodi acpa presenc rf acpa predict ra sever data influenc acpa titer ra cours limit | D001172;D015166;D011859 | T058;T047;T060 |
34,672,446 | extra periton pack exsanguin pelvic hemorrhag emerg depart extra periton pack epp quick high effect method control pelvic hemorrhag | D058734;D050723;D006488;D010388;D011183;D013530;D020246 | T023;T047;T046;T061;T037 |
34,672,445 | predict valu high mean platelet volum earli diagnosi venous thromboembol venous thromboembol vte serious diseas demand fast accur diagnosi begin suitabl treatment present major problem emerg depart ed confirm requir adequ evalu | D042241;D054556 | T047;T060 |
34,672,444 | robot assist heller myotomi safe oper surgic myotomi best therapeut option patient achalasia minim invas techniqu consid prefer method mani surgeon robot assist laparoscop myotomi sever advantag convent laparoscop surgeri benefit includ accur incis may result lower rate intra oper complic | D004931;D000074434;D061646;D011183;D065287 | T047;T079;T061;T046 |
34,672,443 | brain motor region diffus tensor imag patient cataton schizophrenia case control studi small proport schizophrenia patient present cataton symptom imag studi suggest brain motor circuit involv under patholog catatonia howev data diffus dysregul circuit cataton schizophrenia scarc | D009044;D012560 | T048;T023;T029 |
34,672,442 | earli neonat c reactiv protein level periventricular leukomalacia cystic periventricular leukomalacia cpvl strong indic subsequ motor development impair prematur infant pauciti public biomark cpvl | D007969 | T047 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.